Private Trust Company’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.62K | Hold |
72
| – | – | ﹤0.01% | 2211 |
|
2025
Q1 | $2.61K | Hold |
72
| – | – | ﹤0.01% | 2210 |
|
2024
Q4 | $3.03K | Hold |
72
| – | – | ﹤0.01% | 2113 |
|
2024
Q3 | $4K | Buy |
72
+24
| +50% | +$1.33K | ﹤0.01% | 2018 |
|
2024
Q2 | $1.97K | Sell |
48
-6
| -11% | -$247 | ﹤0.01% | 2152 |
|
2024
Q1 | $2.52K | Hold |
54
| – | – | ﹤0.01% | 2084 |
|
2023
Q4 | $2.58K | Hold |
54
| – | – | ﹤0.01% | 2086 |
|
2023
Q3 | $1.93K | Hold |
54
| – | – | ﹤0.01% | 2125 |
|
2023
Q2 | $2.49K | Hold |
54
| – | – | ﹤0.01% | 2070 |
|
2023
Q1 | $2.17K | Sell |
54
-8
| -13% | -$321 | ﹤0.01% | 2067 |
|
2022
Q4 | $3K | Sell |
62
-9
| -13% | -$435 | ﹤0.01% | 1956 |
|
2022
Q3 | $3K | Buy |
71
+28
| +65% | +$1.18K | ﹤0.01% | 1823 |
|
2022
Q2 | $3K | Buy |
+43
| New | +$3K | ﹤0.01% | 1896 |
|